NABC Report 17: Agricultural Biotechnology: Beyond Food and Energy to Health and the Environment
Published 2005 by NABC.
This conference focused on issues such as plants as new sources of medicinals; bioremediation, phytosensing, and ecorestoration; gene-to-product development; and regulation, consumer acceptance, and risk management.
The products and processes addressed here are almost all at the research stage, whereas there is up to 15 years’ experience with commercial products in the enzyme and crop areas. Economic and environmental benefits of the products discussed could be large, e.g. plants engineered to produce low-cost medicinals with ease of scale-up stated as a unique advantage compared to traditional methods of manufacturing pharmaceuticals, plants that remediate soils in situ instead of wholesale excavation and landfill placement, and trees modified for lower lignin content so as to decrease processing costs while increasing pulp yields with less environmental impact. However, all have major not-yet-well-defined regulatory hurdles to navigate. This report provides cutting-edge information on a cross-section of these novel products and processes and includes open dialog on regulatory and related issues. It emerged that some academic scientists believe that biotechnology products are over-regulated, because regulation is based on process not trait.
All, including those from industry and the Biotechnology Industry Organization, support the necessity for regulation. The bottom line is cautious optimism for commercial use of these products; at this time there are few green lights, many yellow and some red.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
(NABC, 2005)The Biotechnology Industry Organization (BIO), has introduced a training program laying out principles for confining plants that make pharmaceuticals and industrial products. Workshops dealing with compliance aspects ...
(NABC, 2005)The 2000 federal government interagency review of regulatory oversight of biotechnology products revealed that ensuring confinement could become a regulatory requirement for approval of some transgenic organisms. In 2001, ...
(NABC, 2005)The past 10 years have been extremely successful for the biotechnology industry. Products that are herbicide-tolerant or produce their own insecticide to control specific pests. These varieties have been widely adopted by ...
The nature of change: Towards sensible regulation of transgenic crops based on lessons from plant breeding, biotechnology and genomics (NABC, 2005)Literature contains many suggestions that plant genomes are highly variable. One early indication was the discovery that maize inbreds differ in the number of rDNA copies. Until the advent of genetic engineering technology ...
(NABC, 2005)Panelists expressed highly critical opinions of industry, government and universities regarding agricultural biotechnology and its products, especially those from cloned animals and PMPs from food crops, identified the ...